Form 8-K - Current report:
SEC Accession No. 0001193125-18-247842
Filing Date
2018-08-14
Accepted
2018-08-14 07:30:34
Documents
3
Period of Report
2018-08-14
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d577459d8k.htm 8-K 16097
2 EX-99.1 d577459dex991.htm EX-99.1 40731
3 GRAPHIC g577459g63k07.jpg GRAPHIC 9008
  Complete submission text file 0001193125-18-247842.txt   70650
Mailing Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2
Business Address BLOCK 2 FLOOR 3, HARCOURT CENTRE HARCOURT STREET DUBLIN L2 2 (872) 225-6077
Iterum Therapeutics plc (Filer) CIK: 0001659323 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38503 | Film No.: 181014260
SIC: 2834 Pharmaceutical Preparations